Knoop C et al. |
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions. |
2005 |
Am. J. Transplant. |
pmid:15888057
|
Kandaswamy R et al. |
A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. |
2005 |
Am. J. Transplant. |
pmid:15888064
|
Cosio FG and Larson TS |
Cardiovascular disease after transplantation: do we know all of the variables? |
2003 |
Am. J. Transplant. |
pmid:12859523
|
Krämer BK et al. |
Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. |
2003 |
Am. J. Transplant. |
pmid:12859533
|
Ciancio G et al. |
The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients. |
2003 |
Am. J. Transplant. |
pmid:12859538
|
Latran M |
Response to Klintmalm on the use of generic immunosuppression. |
2012 |
Am. J. Transplant. |
pmid:22176636
|
Ellis CL and Racusen LC |
Mild rise in creatinine six months post kidney transplant. |
2012 |
Am. J. Transplant. |
pmid:22845913
|
Xu H et al. |
The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. |
2014 |
Am. J. Transplant. |
pmid:24472192
|
Qazi Y et al. |
Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data. |
2017 |
Am. J. Transplant. |
pmid:27775865
|
Boudjema K et al. |
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. |
2011 |
Am. J. Transplant. |
pmid:21466650
|
Knechtle SJ |
Guidance for liver transplant immunosuppression. |
2011 |
Am. J. Transplant. |
pmid:21466652
|
Budde K et al. |
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. |
2014 |
Am. J. Transplant. |
pmid:25278376
|
O'Grady JG et al. |
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. |
2007 |
Am. J. Transplant. |
pmid:17109723
|
Böhmig GA et al. |
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17109725
|
Ferguson R et al. |
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21114656
|
Hirsch HH et al. |
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23137180
|
Naesens M et al. |
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17608835
|
Klintmalm GB |
Immunosuppression, generic drugs and the FDA. |
2011 |
Am. J. Transplant. |
pmid:21794082
|
Shihab FS et al. |
Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. |
2013 |
Am. J. Transplant. |
pmid:23167508
|
Forns X and Navasa M |
Cyclosporine A or tacrolimus for hepatitis C recurrence? An old debate. |
2011 |
Am. J. Transplant. |
pmid:21797970
|
Alloway RR et al. |
A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. |
2012 |
Am. J. Transplant. |
pmid:22759200
|
Wlodarczyk Z et al. |
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. |
2009 |
Am. J. Transplant. |
pmid:19681813
|
Chisholm-Burns MA et al. |
Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681814
|
Schold JD and Kaplan B |
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. |
2009 |
Am. J. Transplant. |
pmid:19681827
|
Troppmann C et al. |
Impact of portal venous pancreas graft drainage on kidney graft outcome in simultaneous pancreas-kidney recipients reported to UNOS. |
2004 |
Am. J. Transplant. |
pmid:15023146
|
Pirenne J et al. |
Tolerance of liver transplant patients to strenuous physical activity in high-altitude. |
2004 |
Am. J. Transplant. |
pmid:15023147
|
Heisel O et al. |
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. |
2004 |
Am. J. Transplant. |
pmid:15023151
|
Hardinger KL et al. |
Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing. |
2004 |
Am. J. Transplant. |
pmid:15023155
|
Suwelack B et al. |
Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy. |
2004 |
Am. J. Transplant. |
pmid:15023160
|
Busque S et al. |
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. |
2009 |
Am. J. Transplant. |
pmid:19660021
|
Vanhove T et al. |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients. |
2017 |
Am. J. Transplant. |
pmid:28224698
|
Shihab F et al. |
Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus. |
2017 |
Am. J. Transplant. |
pmid:28141897
|
Larson TS et al. |
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. |
2006 |
Am. J. Transplant. |
pmid:16468960
|
Vitko S et al. |
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. |
2006 |
Am. J. Transplant. |
pmid:16468962
|
Heller T et al. |
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17532750
|
Grenda R et al. |
A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. |
2010 |
Am. J. Transplant. |
pmid:20420639
|
Knechtle SJ et al. |
Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. |
2009 |
Am. J. Transplant. |
pmid:19344431
|
Grinyo JM et al. |
Pilot randomized study of early tacrolimus withdrawal from a regimen with sirolimus plus tacrolimus in kidney transplantation. |
2004 |
Am. J. Transplant. |
pmid:15268733
|
Schussler T et al. |
Severe hepatitis C infection in a renal transplant recipient following hepatitis C genotype mismatch transplant. |
2004 |
Am. J. Transplant. |
pmid:15268744
|
Nijhoff MF et al. |
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression. |
2016 |
Am. J. Transplant. |
pmid:26288226
|
Bunnapradist S et al. |
Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. |
2013 |
Am. J. Transplant. |
pmid:23279614
|
Ceschi A et al. |
Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. |
2013 |
Am. J. Transplant. |
pmid:23279718
|
Toso C et al. |
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. |
2006 |
Am. J. Transplant. |
pmid:16611343
|
Lacaille F et al. |
Severe dysimmune cytopenia in children treated with tacrolimus after organ transplantation. |
2006 |
Am. J. Transplant. |
pmid:16611346
|
Kaplan B and Kirk AD |
Tacrolimus and sirolimus: when bad things happen to good drugs. |
2006 |
Am. J. Transplant. |
pmid:16827845
|
McAlister VC et al. |
Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. |
2006 |
Am. J. Transplant. |
pmid:16827858
|
Pallet N et al. |
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. |
2016 |
Am. J. Transplant. |
pmid:26990694
|
Barbas AS et al. |
Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. |
2013 |
Am. J. Transplant. |
pmid:23331705
|
Fujishiro J et al. |
Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation. |
2010 |
Am. J. Transplant. |
pmid:20642681
|
Martinez F et al. |
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. |
2010 |
Am. J. Transplant. |
pmid:20642691
|